Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 4:28 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.
View All Commentary (CRTX)
Recs
jegray88 (< 20) Submitted: 10/17/07 12:16 PM : Start Price: $2.40 CRTX Score: -55.46
Recent gov't approval for a sustained release asthma medication. Young company partnering with older more stabilized companies to work on innovations in medicine.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK